Health Care & Life Sciences » Pharmaceuticals | KPC Pharmaceuticals Inc.

KPC Pharmaceuticals Inc. | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
844
791
1,478
1,416
1,461
1,307
Total Accounts Receivable
585
678
795
939
1,313
1,514
Inventories
565
591
616
862
1,133
1,174
Other Current Assets
64
114
112
143
148
207
Total Current Assets
2,058
2,174
3,000
3,360
4,056
4,201
Net Property, Plant & Equipment
494
668
762
856
1,034
1,223
Total Investments and Advances
1
212
646
552
468
574
Intangible Assets
280
370
405
519
643
680
Other Assets
3
41
65
33
13
56
Total Assets
2,886
3,518
4,948
5,402
6,338
6,892
ST Debt & Current Portion LT Debt
294
415
322
321
481
Accounts Payable
317
296
314
372
558
Income Tax Payable
20
28
50
42
77
Other Current Liabilities
342
389
477
618
922
Total Current Liabilities
973
1,128
1,163
1,352
2,037
Long-Term Debt
-
-
298
298
339
Deferred Taxes
50
53
69
74
97
Other Liabilities
-
23
28
10
3
Total Liabilities
973
1,151
1,489
1,669
2,408
Common Equity (Total)
1,758
2,137
3,312
3,558
3,666
Total Shareholders' Equity
1,758
2,137
3,312
3,558
3,666
Total Equity
1,879
2,271
3,336
3,612
3,774
Liabilities & Shareholders' Equity
2,886
3,518
4,948
5,402
6,338
Accumulated Minority Interest
121
134
24
54
108
Non-Equity Reserves
33
95
123
121
157

About KPC Pharmaceuticals

View Profile
Address
No. 166 Keyi Road
Kunming Yunnan 650106
China
Employees -
Website http://www.kpc.com.cn
Updated 07/08/2019
KPC Pharmaceuticals, Inc. engages in the research and development, manufacture, sale, commercial wholesale, and international marketing of drugs. It focuses on natural herbal-based Chinese medicine, chemical medicine, and pharmaceutical area. Its products include panax notoginseng, gastrodine, artemether, and special botanical drugs.